Q-Med AB

Type: Company

Name: Q-Med AB

Nationality: Sweden

Web Address: http://www.q-med.com/

Fact Sheet: Fact Sheet for Q-Med AB

First reported May 14 2013 - Updated May 14 2013 - 2 reports

Valeant Pharmaceuticals International

Allergan's Global Dominance in Facial Injectables Challenged by Acquisitions and Partnership Agreements Among Competitors

TORONTO(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO )This is especially true given the number of acquisitions and partnership agreements that have occurred in the facial injectable market. For example, Q-Med, which manufactured the popular ... [Published Bio-Medicine - May 14 2013]

Entities: Dermik Laboratories Inc, Acquisition, DYSPORT, Restylane, Valeant Pharmaceuticals International

Quotes

"Seit dem vergangenen Jahr haben wir aus Bioventus als einem US-amerikanischen Unternehmen einen wahren Global Player gemacht, der von einem begabten Team von Produkt- und Vertriebsexperten, einem verstärkten Fokus auf Kundenbetreuung und -support sowie führenden Produkten für die Stimulation des Knochenwachstums und Schmerzlinderung bei Arthrose unterstützt wird" , sagte Mark Augusti, CEO von Bioventus

Bioventus nimmt Betrieb in Deutschland auf [Published FinanzNachrichten.de - May 06 2013]

...N). But the way the company identified and tested patients in that study "can ... make it difficult to interpret the results of such a comparison" FDA staff wrote...

U.S. Food and Drug Administration staff have flagged concerns over company data for Q-Med AB's (Q ... [Published Reuters (abstract) - Aug 17 2009]

More Content

sort by: Date \| Relevance
Allergan's Global Dominance in Facial Injectabl... [Published Bio-Medicine - May 14 2013]
Allergan's Global Dominance in Facial Injectabl... [Published NewsBlaze - May 14 2013]
Bioventus nimmt Betrieb in Deutschland auf [Published FinanzNachrichten.de - May 06 2013]
Restylane [Published Article Motron - Apr 29 2013]
TikoMed starts clinical Phase I/II study with T... [Published Equities.com - Apr 29 2013]
TikoMed starts clinical Phase I/II study with T... [Published Zecco - Apr 29 2013]
Research and Markets: Collagen and HA-Based Bio... [Published Yahoo! Finance - Mar 26 2013]
B Vitamins And Folic Acid Do Not Reduce Colorec... [Published BioPortfolio - Oct 14 2012]
Ligandindependent activation of EphA2 by arachi... [Published BioPortfolio - Oct 05 2012]
Biography for Kristin Ermanbriks [Published Silobreaker - Sep 29 2012]
Biography for Anders Blom [Published Silobreaker - Sep 29 2012]
Biography for Bengt Ågerup [Published Silobreaker - Sep 29 2012]
Fact Sheet for NXT2B AB [Published Silobreaker - Sep 29 2012]
Discovered An AminoAcid Deficiency That Causes ... [Published BioPortfolio - Sep 11 2012]
Denosumab superior to zoledronic acid for breas... [Published BioPortfolio - Aug 14 2012]
FDA: Brief Summary (August 18-19, 2009: Orthopa... [Published FDA - Aug 19 2009]
U.S. Food and Drug Administration staff have fl... [Published Reuters (abstract) - Aug 17 2009]
The U.S. Food and Drug Administration said Duro... [Published WSJ - Aug 14 2009]
Fact Sheet for Q-Med AB [Published Silobreaker - May 18 2009]
Fact Sheet for Q-Med AB [Published Able2Act - Jul 16 2008]
Fact Sheet for Q-Med [Published Able2Act - Feb 12 2008]
Biography for Bertil Hult [Published Able2Act - Jan 03 2008]
FDA: Summary from the General and Plastic Surge... [Published FDA - Nov 21 2003]